Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers
The agreed-upon workshop conclusions provide a basis for key considerations while undertaking future drug development activities for children with poor-prognosis cancers, ensuring that the needs and perspectives of all stakeholders are factored in from the outset.
Authors
- Steven G. DuBois (ORCID: https://orcid.org/0000-0003-0882-738X)
- Donna Neuberg (ORCID: https://orcid.org/0000-0003-2566-3145)
- Michela Casanova (ORCID: https://orcid.org/0000-0003-0368-7883)
- Victoria Buenger (ORCID: https://orcid.org/0000-0001-9241-6668)
- Patricia Blanc (ORCID: https://orcid.org/0000-0002-7318-8986)
- Claudia Rössig (ORCID: https://orcid.org/0000-0002-8672-5285)
- Gregory H. Reaman (ORCID: https://orcid.org/0000-0002-6698-4503)
- Delphine Heenen (ORCID: https://orcid.org/0000-0002-7703-9902)
- Quentin Campbell-Hewson (ORCID: https://orcid.org/0000-0003-1509-6925)
- Teresa de Rojas (ORCID: https://orcid.org/0000-0001-7749-8423)
- Nicole Scobie (ORCID: https://orcid.org/0000-0002-6539-2741)
- Anja Schiel (ORCID: https://orcid.org/0000-0002-1258-4731)
- Andrew D.J. Pearson (ORCID: https://orcid.org/0000-0002-8738-5913)
- Nick Bird (ORCID: https://orcid.org/0000-0003-1808-8584)
- Sara Wakeling (ORCID: https://orcid.org/0000-0002-3563-0390)
- Gilles Vassal (ORCID: https://orcid.org/0000-0003-1780-8869)
- Antonia Palmer (ORCID: https://orcid.org/0000-0002-2665-7305)
- Donna Ludwinski (ORCID: https://orcid.org/0000-0003-4717-7690)
- Julia Glade Bender (ORCID: https://orcid.org/0000-0001-5316-6440)
- Leona Knox (ORCID: https://orcid.org/0000-0002-5218-3895)
- Xavier Paolettí (ORCID: https://orcid.org/0000-0002-1250-0040)
- Willemijn Plieger-van Solkema (ORCID: https://orcid.org/0000-0003-3911-477X)
- Lucas Moreno (ORCID: https://orcid.org/0000-0002-0708-1670)
- Pablo Berlanga
- Ann Graham
- Christina Ip-Toma
Institutions
- United States Food and Drug Administration (US)
- Memorial Sloan Kettering Cancer Center (US)
- Inserm (FR)
- Institut Gustave Roussy (FR)
- Direktoratet for medisinske produkter (NO)
- London Cancer (GB)
- University Hospital Münster (DE)
- Stichting Kinderoncologie Nederland (NL)
- Dana-Farber Cancer Institute (US)
- Princess Máxima Center (NL)
- Solving Kids' Cancer (US)
- Vall d'Hebron Hospital Universitari (ES)
- Great North Children's Hospital (GB)
- Coalition Against Childhood Cancer (US)
- MIB Agents (US)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Institut des Maladies Génétiques Imagine (FR)
- Anticancer Fund (BE)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
- Institut Curie (FR)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.49239
- Citations
- 2
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 2.22